Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes. The company was founded in 2018 and is based in San Francisco, CA.

Biotechnology

Health Care

Therapeutics

Quanta Therapeutics

Michael Kramer

Nirav R. Kapadia

Alfred Lordi

Yang Zhang

The Scientific Research Team at Quanta Therapeutics is dedicated to discovering and developing innovative cancer therapies through allosteric modulation of driver oncogenes. Comprised of experts in medicinal chemistry, preclinical biology, and research science, the team collaborates to design experiments, analyze data, and advance novel therapeutic candidates from initial concept to preclinical evaluation, ultimately aiming to improve treatment outcomes for cancer patients.

Scientific Research Team

The Leadership Team at Quanta Therapeutics is responsible for driving the strategic vision and operational excellence of the company. Comprising key executives in scientific and development operations as well as medical leadership, the team collaborates to guide innovative cancer therapies from concept through clinical development, ensuring alignment with scientific goals and regulatory requirements. Their collective expertise fosters a culture of innovation and rigor, ultimately aiming to deliver transformative treatment options for patients.

Quanta Therapeutics

Org chart

Teams

Scientific Research Team

Leadership Team

Offices

Quanta Therapeutics

Org chart

Teams

Scientific Research Team

Leadership Team

Offices

Related companies